A Prospective Post-marketing Observational Study Assessing the Safety and Efficacy of Nerivio for Migraine Prevention.
Clinical trial NCT05940870 · COMPLETED
Trial details
- NCT number
- NCT05940870
- Sponsor
- Theranica
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-03
- Primary completion
- 2024-06-30
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.